Alpa Laboratories Limited
ALPA · NSE · Healthcare
StocksWizard rates Alpa Laboratories Limited a Hold, scoring 54/100 on our blended model. At ₹68.11 it trades below our blended DCF and relative-multiples fair value of ₹136.22, implying roughly 100% upside to that estimate — we read the stock as undervalued by 100%. Financial health scores 54/100 (grade C), in the safe band on the Altman Z-score, with a Piotroski F-score of 4/9. It clears 7 of 12 investability checks, with durability 61, valuation 100 and momentum 29 on our 0–100 scales.
These are StocksWizard's own estimates from end-of-day public data — see how we calculate them. For information only, not investment advice.
With a 20% margin of safety, our buy-below price is ₹108.98. Low-confidence estimate — limited data.
Piotroski F-score 4/9 — quality of earnings & balance sheet.
Investability checklist
- ✕ROE above 15%8.4%
- ✓Low debt (D/E < 0.5)0.01x
- ✓Positive free cash flow
- ✕Revenue growth > 10%-21%
- –Earnings growing
- ✓Net margin ≥ 10%14.2%
- ✓Current ratio > 1.54.01
- ✓Below our fair value
- ✓Margin of safety ≥ 20%
- ✕Above 200-day average
- ✕Above 50-day average
- –Positive 1-year return
- ✓Altman Z in safe zoneZ 3.15
- ✕Piotroski ≥ 74/9
1-year price
EOD · 2026-06-19Our scores
Durability rewards strong, low-debt, profitable businesses; Valuation rewards stocks cheap vs their sector; Momentum rewards strong price trends.
Quarterly results
Annual financials
Shareholding
Promoter holding via insider stake; institutional via reported holdings.
Key fundamentals
SWOT snapshot
Strengths
- •Lightly leveraged balance sheet.
- •Financially solid — Altman Z 3.15.
Weaknesses
- •Price below its 200-day moving average (downtrend).
Opportunities
- •Trading in our value buy zone versus sector peers.
- •Trades ~100% below our estimated fair value.
About Alpa Laboratories Limited
Alpa Laboratories Limited engages in the manufacture and sale of drugs and chemicals in India. It provides formulations that address various therapeutic segments. The company was incorporated in 1988 and is based in Indore, India.
More in Healthcare
All stocksOur verdict, fair value, financial-health and checklist are StocksWizard's own estimates, computed from public end-of-day data using standard models (DCF, relative valuation, Altman Z, Piotroski). For information only — not investment advice or a recommendation. Verify independently before investing.